Transdermal drug delivery systems, devices, and methods employing novel pharmaceutical vehicles
First Claim
Patent Images
1. An iontophoretic drug delivery device for providing transdermal delivery of one or more therapeutic active agents to a biological interface, comprising:
- an active electrode assembly including at least one active electrode element; and
at least one active agent reservoir, the at least one active agent reservoir including a pharmaceutically acceptable vehicle for transporting one or more active agents, the pharmaceutically acceptable vehicle comprising at least one surfactant, at least one nonpolar solvent, and at least one polar agent;
the at least one active electrode element operable to provide an electromotive force for driving the pharmaceutically acceptable vehicle from the at least one active agent reservoir to the biological interface.
5 Assignments
0 Petitions
Accused Products
Abstract
Systems, devices, and methods for transdermal delivery of one or more therapeutic active agents to a biological interface. An iontophoretic drug delivery system is provided for transdermal delivery of one or more therapeutic active agents to a biological interface of a subject. The iontophoretic drug delivery system includes at least one active agent reservoir. The one or more active agent reservoirs are loadable with a vehicle for transporting, delivering, encapsulating, and/or carrying the one or more active agents
-
Citations
53 Claims
-
1. An iontophoretic drug delivery device for providing transdermal delivery of one or more therapeutic active agents to a biological interface, comprising:
-
an active electrode assembly including at least one active electrode element; and
at least one active agent reservoir, the at least one active agent reservoir including a pharmaceutically acceptable vehicle for transporting one or more active agents, the pharmaceutically acceptable vehicle comprising at least one surfactant, at least one nonpolar solvent, and at least one polar agent;
the at least one active electrode element operable to provide an electromotive force for driving the pharmaceutically acceptable vehicle from the at least one active agent reservoir to the biological interface. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27)
-
-
28. A method of making an active agent laminate for an iontophoretic drug delivery device that provides transdermal delivery of one or more therapeutic active agents to a biological interface, comprising:
-
preparing a lipophilic composition comprising a first surfactant and a nonpolar solvent;
preparing a hydrophilic composition comprising a second surfactant and a polar agent;
mixing the lipophilic composition and the hydrophilic composition using a high-shear mixer to form a pharmaceutically acceptable vehicle having a lipophilic phase and a hydrophilic phase;
impregnating at least one substrate with the pharmaceutically acceptable vehicle;
forming a multi-layer active agent laminate including the at least one substrate with the pharmaceutically acceptable vehicle and at least one delivery rate controlling membrane; and
physically coupling the multi-layer active agent laminate to an active electrode assembly of an iontophoretic drug delivery device, the active electrode assembly including at least one active electrode element operable to provide an electromotive force to drive at least some of the pharmaceutically acceptable vehicle from the multi-layer active agent laminate to a biological interface. - View Dependent Claims (29, 30, 31, 32, 33)
-
-
34. An article of manufacture for transdermal administration of medication by iontophoresis, comprising:
-
an iontophoretic drug delivery device comprising an active electrode assembly comprising at least one active electrode element and at least one active agent reservoir, the at least one active agent reservoir including a pharmaceutically acceptable vehicle comprising at least one surfactant, at least one nonpolar solvent, and at least one polar agent, the at least one active electrode element operable to provide an electromotive force to drive one or more active agents from the at least one active agent reservoir;
at least one dosage form comprising one or more active agents selected from analgesics, anesthetics, or combinations thereof, the at least one dosage form loaded in the pharmaceutically acceptable vehicle; and
a package insert providing instructions for transdermally administering, to a subject in need of pain therapy, a therapeutically effective amount of the at least one dosage form. - View Dependent Claims (35)
-
-
36. A method for transdermal administration of at least one analgesic or anesthetic by iontophoresis, comprising:
-
positioning an active electrode assembly and a counter electrode assembly of an iontophoretic delivery device on a biological interface of a subject, the active electrode including an active agent reservoir comprising at least one analgesic or anesthetic active agent carried by a pharmaceutically acceptable vehicle comprising at least one surfactant, at least one nonpolar solvent, and at least one polar agent; and
applying a sufficient amount of current to transport the at least one analgesic or anesthetic active agent from the active agent reservoir, to the biological interface of the subject, and to administer a therapeutically effective amount of the at least one analgesic or anesthetic active agent to produce analgesic or anesthetic therapy in the subject for a limited period of time. - View Dependent Claims (37, 38, 39, 40)
-
-
41. An iontophoretic drug delivery device for providing transdermal delivery of one or more therapeutic active agents to a biological interface, comprising:
-
an active electrode assembly including at least one active electrode element; and
at least one active agent reservoir, the at least one active agent reservoir including a pharmaceutically acceptable vehicle comprising a plurality of first vesicles;
wherein the plurality of first vesicles are selected from liposomes, nisomes, ethasomes, transfersomes, virosomes, cyclic oligosaccharides, non ionic surfactant vesicles, and phospholipid surfactant vesicles;
at least some of the first vesicles including one or more therapeutic active agents; and
the at least one active electrode element operable to provide an electromotive force to drive at least some of the pharmaceutically acceptable vehicle comprising the plurality of first vesicles;
from the at least one active agent reservoir to the biological interface. - View Dependent Claims (42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53)
-
Specification